COVID-19 Pneumonia in two Patients with Ankylosing Spondylitis Using Anti-TNF Agents

dc.contributor.authorKurt, İdris
dc.contributor.authorEdis, Ebru Çakır
dc.contributor.authorMert, Habibe Tülin Elmaslar
dc.date.accessioned2024-06-12T10:05:39Z
dc.date.available2024-06-12T10:05:39Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThe new type of coronavirus (SARS-CoV2) reported to have originated in China in December 2019 has spread rapidly all over the world and has become a global problem. COVID-19 is more common and more severe in people with such comorbidities as cardiovascular disease, hypertension and diabetes. There is a lack of consensus on whether rheumato- logical diseases and drugs used in their treatment increase the risk of developing COVID-19. There is also lack of data in literature regarding the develop- ment of COVID-19, especially in patients with Anky- losing Spondylitis. This case presentation relates to two patients with Ankylosing Spondylitis using anti- TNF agents who were affected by COVID-19. The younger of the two, who had no comorbidities, healed quickly with antiviral and supportive therapy, while the older patient, who had cardiovascular and chronic kidney comorbidities, experienced an aggres- sive disease course and did not survive. The course of COVID-19 infection and mortality is strongly con- nected with underlying comorbidities. Our focus here is on rheumatological diseases, their immunosup- pressive treatments and their impact on the course of the novel type Coronavirus infection, based on two cases of Ankylosing Spondylitis, in light of literature.en_US
dc.identifier.doi10.5505/respircase.2021.60565
dc.identifier.endpage82en_US
dc.identifier.issn2147-2475
dc.identifier.issue2en_US
dc.identifier.startpage78en_US
dc.identifier.trdizinid504856en_US]
dc.identifier.urihttps://doi.org/10.5505/respircase.2021.60565
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/504856
dc.identifier.urihttps://hdl.handle.net/20.500.14551/13570
dc.identifier.volume10en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofRespiratory Case Reportsen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleCOVID-19 Pneumonia in two Patients with Ankylosing Spondylitis Using Anti-TNF Agentsen_US
dc.typeArticleen_US

Dosyalar